(Q40680672)

English

Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer

scientific article published on November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer (English)

1 reference

Europe PubMed Central

22 September 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

William W Tseng

1

1 reference

Europe PubMed Central

22 September 2017

Adriana Deganutti

2

1 reference

Europe PubMed Central

22 September 2017

May N Chen

3

1 reference

Europe PubMed Central

22 September 2017

Romaine E Saxton

4

1 reference

Europe PubMed Central

22 September 2017

Carson D Liu

5

1 reference

Europe PubMed Central

22 September 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

22 September 2017

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

22 September 2017

6

1 reference

Europe PubMed Central

22 September 2017

838-43; discussion 844

1 reference

Europe PubMed Central

22 September 2017

6

1 reference

Europe PubMed Central

22 September 2017

https://scigraph.springernature.com/pub.10.1016/s1091-255x(02)00061-6

0 references

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting angiogenic processes by combination rofecoxib and ionizing radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The tumor suppressor ING1: structure and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The molecular and cellular biology of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2000.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of cyclooxygenase-2 in carcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12504222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1091-255X(02)00061-6

1 reference

Europe PubMed Central

22 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40680672&oldid=1967264799"